Skip to content

Effect of voluven on post spinal headache in patients with cesarean section

Effect of voluven on post spinal headache in patients with cesarean section

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308243305N5
Enrollment
200
Registered
2014-12-20
Start date
2013-07-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post spinal headache. Other specified headache syndromes

Interventions

Intervention 1: Intervention: administration of 5-7ml/kg voluven after spinal anesthesia. Intervention 2: Control:administration of 5-7ml/kg ringer serum after spinal anesthesia.
Prevention
Intervention: administration of 5-7ml/kg voluven after spinal anesthesia
Control:administration of 5-7ml/kg ringer serum after spinal anesthesia

Sponsors

Vice-chancellor Of Research Babol University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: All of patients who are candidates for Cesarean section with Spinal anesthesia. Exclusion Criteria: Patients contraindicated of LP; psychotic or patients with space occupying lesion; addicts; corticosteroid and NSAID users.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Headache. Timepoint: daily until one week post spinal headache. Method of measurement: Question & answer.

Secondary

MeasureTime frame
Blood pressure. Timepoint: During spinal anesthesia. Method of measurement: BP Cuff.;Heart rate. Timepoint: During spinal anesthesia. Method of measurement: ECG.;Nausea & Vomiting. Timepoint: During spinal anesthesia. Method of measurement: Question & answer.;Arterial oxygen saturation. Timepoint: During spinal anesthesia. Method of measurement: pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ebrahim Alijanpour

Babol University Of Medical Sciences

dralijanpour@yahoo.com, ans_dep@yahoo.com+98 11 1223 8296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026